The common methods of treatment for cancer are targeted therapy and immunotherapy such as immune checkpoint inhibitors (ICIs) and tyrosine kinase inhibitors (TKIs), the PD-1/PD-L1 axis, as well as cytotoxic T-lymphocyte antigen-4 (CTLA-4) (1). This evidence concerns the gene CD274 and cancer.